keyword
https://read.qxmd.com/read/38029953/cardioprotective-polyphenols-from-geum-japonicum%C3%A2-var-chinense
#21
JOURNAL ARTICLE
Tong Wu, Fangbo Zhang, Qingqing Cai, Hongwei Wu, Tong Jiang, Lixia Wang, Xiaoxu Chen, Peiyun Gao, Xiaoyun Yang, Yingying Chen, Chunyu Yue, Liying Tang, Zhuju Wang
Seven undescribed tannins, namely gejaponin A-G, and one dehydrodigallic acid derivative 3,4-dihydroxy-5-(3,4,5-trihydroxy-1-ethoxycarbonyl phenoxy)benzoic acid, together with eighteen known polyphenols were isolated from the 95% ethanol extract of the aerial part of Geum japonicum Thunb. var. chinense F. Bolle. Their structures were elucidated on the basis of comprehensive analysis of UV, IR, NMR, HRMS, and CD spectroscopy experiments. To evaluate their bioactivities, sixteen major compounds were selected to intervene in hydrogen peroxide (H2 O2 )-induced oxidative damage on H9c2 rat cardiomyoblasts...
November 27, 2023: Phytochemistry
https://read.qxmd.com/read/37971510/prospective-affirmative-therapeutics-of-cannabidiol-oil-mitigates-doxorubicin-induced-abnormalities-in-kidney-function-inflammation-and-renal-tissue-changes
#22
JOURNAL ARTICLE
Nabil A Soliman, Samih I El Dahmy, Amr A Shalaby, Khadija A Mohammed
Nephropathy is the decline in kidney function. A promising treatment for numerous types of illness is using natural materials as natural chemical compounds. The inquiry was conducted to investigate cannabidiol (CBD) potential for renal syndrome protection. The five equal groups of fifty male Sprague-Dawley rats weighing 150 ± 25 g each were designed; group I received distilled water orally, while group II got an intraperitoneal injection of doxorubicin (18 mg/kg bwt). Group III received CBD (26 mg/kg bwt) orally, while group IV received 1 ml of CBD (26 mg/kg bwt) and group V received trimetazidine (10 mg/kg bwt), in addition to a single intraperitoneal dose of doxorubicin (18 mg/kg bwt) on the 11th day for both groups (IV, V)...
November 16, 2023: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/37932729/high-fat-stimulation-induces-atrial-neural-remodeling-by-reducing-no-production-via-the-crif1-enos-p21-axi
#23
JOURNAL ARTICLE
An Zhang, Huilin Li, Qiyuan Song, Yansong Cui, Yujiao Zhang, Ximin Wang, Zhan Li, Yinglong Hou
BACKGROUND: Autonomic remodeling of the atria plays a pivotal role in the development of atrial fibrillation (AF) and exerts a substantial influence on the progression of this condition. Hyperlipidemia is a predisposing factor for AF, but its effect on atrial nerve remodeling is unclear. The primary goal of this study was to explore the possible mechanisms through which the consumption of a high-fat diet (HFD) induces remodeling of atrial nerves, and to identify novel targets for clinical intervention...
November 6, 2023: Lipids in Health and Disease
https://read.qxmd.com/read/37897405/styrax-liquidambar-orientalis-mill-promotes-mitochondrial-function-and-reduces-cardiac-damage-following-myocardial-ischemic-injury-the-role-of-the-ampk-pgc1%C3%AE-signaling-pathway
#24
JOURNAL ARTICLE
Fei Mu, Jiaxin Zhao, Meina Zhao, Rui Lin, Kedi Liu, Shi Zhao, Xingru Tao, Weihong Li, Qi Dai, Miaomiao Xi, Haifeng Tang, Jingwen Wang
OBJECTIVES: To explore the effect of extract of Styrax (ES) on myocardial ischemic injury and its molecular mechanism, indirectly providing a theoretical basis for the development of ES. METHODS: In order to assess the impact of ES treatment on ischemic heart disease, both a left anterior descending ligation-induced myocardial infarction (MI) model and an ischemia/hypoxia (I/H)-induced H9c2 cell injury model have been constructed. Specifically, Sprague-Dawley rats were randomly assigned to the following groups (n = 8) and administered intragastrically once a day for seven consecutive days: Sham group, MI group, ES-L (0...
October 28, 2023: Journal of Pharmacy and Pharmacology
https://read.qxmd.com/read/37886007/effect-of-trimetazidine-against-ovarian-ischemia-reperfusion-injury-in-rat-model-a-new-pathway-jak2-stat3
#25
JOURNAL ARTICLE
Tugba Nurcan Yuksel, Zekai Halici, Elif Cadirci, Erdem Toktay, Bengül Ozdemir, Ayşe Bozkurt
OBJECTIVES: Ovarian ischemia/reperfusion (I/R) is an extremely complex pathological problem that begins with oxygen deprivation, progresses to excessive free radical production, and intensifies inflammation. The JAK2/STAT3 signaling pathway is a multipurpose signaling transcript channel that plays a role in several biological functions. Trimetazidine (TMZ) is a cellular anti-ischemic agent. This study aims to investigate the effects of TMZ on ovarian I/R injury in rats. MATERIALS AND METHODS: sixty four rats were divided into 8 groups at random: healthy(group1); healthy+TMZ20(group2); ischemia (I) (group 3); I+TMZ10(group4); I+ TMZ20(group5); I/R(group6); I/R+TMZ10(group7); I/R+TMZ20(group8)...
2023: Iranian Journal of Basic Medical Sciences
https://read.qxmd.com/read/37865040/evaluating-the-protective-role-of-trimetazidine-versus-nano-trimetazidine-in-amelioration-of-bilateral-renal-ischemia-reperfusion-induced-neuro-degeneration-implications-of-erk1-2-jnk-and-galectin-3-nf-%C3%AE%C2%BAb-tnf-%C3%AE-hmgb-1-signaling
#26
JOURNAL ARTICLE
Fatma E Hassan, Basma Emad Aboulhoda, Isra H Ali, Heba M Elwi, Lamiaa M Matter, Hend Ahmed Abdallah, Mohamed Mansour Khalifa, Asmaa Selmy, Mansour A Alghamdi, Suzan Awad Morsy, Basant A Al Dreny
BACKGROUND: Renal ischemia/reperfusion (I/R) is a primary culprit of acute kidney injury. Neurodegeneration can result from I/R, but the mechanisms are still challenging. We studied the implications of bilateral renal I/R on brain and potential involvement of the oxidative stress (OS) driven extracellular signal-regulated kinase1/2, c-Jun N-terminal kinase (ERK1/2, JNK) and Galectin-3 (Gal-3)/nuclear factor Kappa B (NF-қB)/tumor necrosis factor-alpha (TNF-α), high mobility group box-1 (HMGB-1), and caspase-3 paths upregulation...
October 16, 2023: Tissue & Cell
https://read.qxmd.com/read/37799033/comprehensive-metabolite-profiling-of-trimetazidine-in-camels-using-high-resolution-accurate-mass-spectrometry-implications-for-doping-control
#27
JOURNAL ARTICLE
Jahfar Nalakath, Rasik Pt, Ahmed Kadry, Ansar Babu Palathinkal, Ondern Komathu Praseen, Ibrahimwaseem Nelliyott, Christiana Hebel, N Selvapalam, E R Nagarajan
RATIONALE: Trimetazidine and its metabolites are prohibited substances in sports. With a growing number of adverse findings in human athletes, it is crucial to develop doping control strategies that include screening for trimetazidine in animal sports. This study aims to detect and characterize trimetazidine and its metabolites for doping control in camel racing. METHODS: Camel urine and plasma samples were collected from four healthy animals following a single oral dose of trimetazidine...
November 15, 2023: Rapid Communications in Mass Spectrometry: RCM
https://read.qxmd.com/read/37702833/trimetazidine-to-reduce-myocardial-fibrosis-competing-interests-with-sglt2-inhibitors
#28
EDITORIAL
Tyler B Moran, Masafumi Kitakaze, Yochai Birnbaum
No abstract text is available yet for this article.
September 13, 2023: Cardiovascular Drugs and Therapy
https://read.qxmd.com/read/37622506/parameters-of-left-ventricular-diastolic-dysfunction-in-patients-with-hypertension-disease-with-concomitant-type-2-diabetes
#29
JOURNAL ARTICLE
Olexandr Bilovol, Iryna Knyazkova, Inna Dunaieva, Olexandr Kiriienko
OBJECTIVE: The aim: To study the parameters of the left ventricular (LV) diastolic function in patients with HT with concomitant T2DM and without it before and after complex treatment with the inclusion of Eplerenone 50 mg per day and Trimetazidine 80 mg per day during 3 months. PATIENTS AND METHODS: Materials and methods: The study included 50 patients, aged 45-54 years (mean age 51.3«1.5 years), women - 24 and men 26 with HT stage II. All patients were divided into 2 groups: 1 group (n=25) - patients with HT stage II (HbA1c level of 5...
2023: Wiadomości Lekarskie: Organ Polskiego Towarzystwa Lekarskiego
https://read.qxmd.com/read/37591408/antitumor-effect-of-trimetazidine-in-a-model-of-solid-ehrlich-carcinoma-is-mediated-by-inhibition-of-glycolytic-pathway-and-akt-signaling
#30
JOURNAL ARTICLE
Reem M Hazem, Rasha Fawzey, Eman T Mehanna, Safaa M Kishk, Mohammed Elsayed, Norhan M El-Sayed
Disturbance in glucose metabolism was proposed to be a pathogenetic mechanism of breast cancer. Trimetazidine (TMZ) inhibits β-oxidation of fatty acids through blocking the activity of 3-ketoacylCoA thiolase enzyme, leading to enhancement of glucose oxidation and metabolic respiration. The present study aimed to examine the cytotoxic effect of TMZ in both in vivo and in vitro models of breast cancer, focusing on its impact on the expression of some glycolytic enzymes and AKT signaling. The cytotoxic effect of TMZ was screened against breast (MCF-7) cancer cell line at different concentrations [0...
August 15, 2023: Chemico-biological Interactions
https://read.qxmd.com/read/37563926/recent-developments-in-targets-for-ischemic-foot-disease
#31
REVIEW
Jonathan Golledge, Shivshankar Thanigaimani, Kristen S Barratt, Gian Paolo Fadini
Diabetes is a key risk factor for ischaemic foot disease, which causes pain, tissue loss, hospital admission, and major amputation. Currently, treatment focuses on revascularisation, but many patients are unsuitable for surgery and revascularisation is frequently unsuccessful. The authors describe recent research in animal models and clinical trials investigating novel medical targets for ischaemia, including theories about impaired wound healing, animal models for limb ischaemia and recent randomised controlled trials testing novel medical therapies...
August 10, 2023: Diabetes/metabolism Research and Reviews
https://read.qxmd.com/read/37556093/comparative-efficacy-of-different-drugs-for-the-treatment-of-dilated-cardiomyopathy-a-systematic-review-and-network-meta-analysis
#32
REVIEW
Xinyu Tong, Lijuan Shen, Xiaomin Zhou, Yudan Wang, Sheng Chang, Shu Lu
BACKGROUND AND OBJECTIVE: At present, the therapies of dilated cardiomyopathy concentrated on the symptoms of heart failure and related complications. The study is to evaluate the clinical efficacy of a combination of various conventional and adjuvant drugs in treating dilated cardiomyopathy via network meta-analysis. METHODS: The study was reported according to the PRISMA 2020 statement. From inception through 27 June 2022, the PubMed, Embase, Cochrane library, and Web of Science databases were searched for randomized controlled trials on medicines for treating dilated cardiomyopathy...
August 9, 2023: Drugs in R&D
https://read.qxmd.com/read/37530098/trimetazidine-in-heart-failure-with-preserved-ejection-fraction-a-randomized-controlled-cross-over-trial
#33
JOURNAL ARTICLE
Arno A van de Bovenkamp, Kiki T J Geurkink, Frank T P Oosterveer, Frances S de Man, Wouter E M Kok, Patrick N A Bronzwaer, Cor P Allaart, Aart J Nederveen, Albert C van Rossum, Adrianus J Bakermans, M Louis Handoko
AIMS: Impaired myocardial energy homeostasis plays an import role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). Left ventricular relaxation has a high energy demand, and left ventricular diastolic dysfunction has been related to impaired energy homeostasis. This study investigated whether trimetazidine, a fatty acid oxidation inhibitor, could improve myocardial energy homeostasis and consequently improve exercise haemodynamics in patients with HFpEF...
August 2, 2023: ESC Heart Failure
https://read.qxmd.com/read/37528808/anti-ischemic-drug-trimetazidine-blocks-mercury-nephrotoxicity-by-suppressing-renal-redox-imbalance-inflammatory-stress-and-caspase-dependent-apoptosis-in-rats
#34
JOURNAL ARTICLE
Azza Sedky, Ademola C Famurewa
Trimetazidine (TMZ) is a promising emerging therapeutic piperazine derivative for renal pathologies. However, the nephroprotective mechanism of TMZ against heavy metal-induced toxicity is unknown. This study, therefore, aimed to explore whether TMZ could mitigate mercury-induced nephrotoxicity in rats. Rats were injected TMZ (3 mg/kg bw) and/or mercury chloride (HgCl2 ) (4 mg/kg bw) for 4 days (n = 6 rats per group). The blood analysis revealed marked increases in creatinine, urea and uric acid levels in HgCl2 group compared to the control...
August 2, 2023: Drug and Chemical Toxicology
https://read.qxmd.com/read/37522701/the-application-of-trimetazidine-in-healthy-individuals-a-systematic-review
#35
JOURNAL ARTICLE
E Bezuglov, A Zholinsky, M Shoshorina, Z Waśkiewicz, A Emanov, R Morgans, V Bertholz, V Zelenskaya, A Lazarev, M Sokolskaya, O Talibov
OBJECTIVE: Currently, there is no evidence to support trimetazidine (TMZ) administration aimed at enhancing physical performance or post-exercise recovery in healthy individuals or athletes from the general and athletic populations, respectively. Considering the lack of empirical data, from a scientific and practical perspective, it would be interesting to review research with high methodological quality that examines the effects of TMZ on healthy individuals and athletes from various age groups...
September 2023: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/37506672/trimetazidine-after-coronary-revascularization-much-ado-about-nothing
#36
JOURNAL ARTICLE
Marco Borgi, Mariangela Peruzzi, Giuseppe Biondi-Zoccai, Francesco Versaci
No abstract text is available yet for this article.
August 1, 2023: Journal of Cardiovascular Pharmacology
https://read.qxmd.com/read/37504543/metabolic-approaches-for-the-treatment-of-dilated-cardiomyopathy
#37
REVIEW
Roberto Spoladore, Giuseppe Pinto, Francesca Daus, Sara Pezzini, Damianos Kolios, Gabriele Fragasso
In dilated cardiomyopathy (DCM), where the heart muscle becomes stretched and thin, heart failure (HF) occurs, and the cardiomyocytes suffer from an energetic inefficiency caused by an abnormal cardiac metabolism. Although underappreciated as a potential therapeutic target, the optimal metabolic milieu of a failing heart is still largely unknown and subject to debate. Because glucose naturally has a lower P/O ratio (the ATP yield per oxygen atom), the previous studies using this strategy to increase glucose oxidation have produced some intriguing findings...
July 5, 2023: Journal of Cardiovascular Development and Disease
https://read.qxmd.com/read/37468497/the-use-of-prescription-drugs-and-health-care-services-during-the-6-month-post-covid-19-period
#38
JOURNAL ARTICLE
Kerli Mooses, Kaarel Vesilind, Marek Oja, Sirli Tamm, Markus Haug, Ruth Kalda, Kadri Suija, Anna Tisler, Tatjana Meister, Maria Malk, Anneli Uusküla, Raivo Kolde
COVID-19 and other acute respiratory viruses can have a long-term impact on health. We aimed to assess the common features and differences in the post-acute phase of COVID-19 compared with other non-chronic respiratory infections (RESP) using population-based electronic health data. We applied the self-controlled case series method where prescription drugs and health care utilisation were used as indicators of health outcomes during the six-month-long post-acute period. The incidence rate ratios of COVID-19 and RESP groups were compared...
July 19, 2023: Scientific Reports
https://read.qxmd.com/read/37456821/the-impact-of-trimetazidine-on-microcirculation-after-stenting-for-stable-coronary-artery-disease-patmos-study
#39
JOURNAL ARTICLE
Ivan Ilic, Stefan Timcic, Maja Milosevic, Srdjan Boskovic, Natalija Odanovic, Matija Furtula, Milan Dobric, Srdjan Aleksandric, Petar Otasevic
BACKGROUND: Myocardial ischemia is caused by epicardial coronary artery stenosis or atherosclerotic disease affecting microcirculation. Trimetazidine (TMZ), promotes glucose oxidation which optimizes cellular energy processes in ischemic conditions. Small studies demonstrated protective effects of TMZ in terms of reducing myocardial injury after percutaneous coronary intervention (PCI), its effect on microcirculation using contemporary investigative methods has not been studied. The aim of the study was to examine effects of trimetazidine, given before elective PCI, on microcirculation using invasively measured index of microcirculatory resistance (IMR)...
2023: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/37437526/impact-of-trimetazidine-on-the-incident-heart-failure-following-coronary-artery-revascularization
#40
JOURNAL ARTICLE
Sangwoo Park, Junhyuk Chang, Seung-Pyo Hong, Eun-Sun Jin, Min Gyu Kong, Ha-Young Choi, Seong Soon Kwon, Gyung-Min Park, Rae Woong Park
Abnormal myocardial metabolism is a common pathophysiological process underlying ischemic heart disease and heart failure (HF). Trimetazidine is an anti-anginal agent with a unique mechanism of action that regulates myocardial energy metabolism and might have a beneficial effect in preventing HF in patients undergoing myocardial revascularization. We aimed to evaluate the potential benefit of trimetazidine in preventing incident hospitalization for HF following myocardial revascularization. Using the common data model, we identified patients without prior HF undergoing myocardial revascularization from eight hospital databases in Korea...
July 11, 2023: Journal of Cardiovascular Pharmacology
keyword
keyword
105832
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.